Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jonah Rainey

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Immunological Methods|July 9, 2013
A mammalian expression system for high throughput antibody screeningLinda Xu, Xiaofang Jin, G Jonah Rainey, et al.
The Journal of Biological Chemistry|March 5, 2017
An antidote approach to reduce risk and broaden utility of antibody-based therapeuticsAlyse D Portnoff, Cuihua Gao, M Jack Borrok, et al.
The Journal of Biological Chemistry|January 20, 2017
Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific AntibodySrinath Kasturirangan, G Jonah Rainey, Linda Xu, et al.
The Journal of Biological Chemistry|July 15, 2017
Use of a neutralizing antibody helps identify structural features critical for binding of <i>Clostridium difficile</i> toxin TcdA to the host cell surfaceHeather K Kroh, Ramyavardhanee Chandrasekaran, Kim Rosenthal, et al.
The Journal of Biological Chemistry|February 8, 2018
Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signalingJenny Sandmark, Göran Dahl, Linda Öster, et al.
The Journal of Biological Chemistry|November 29, 2017
A neutralizing antibody that blocks delivery of the enzymatic cargo of <i>Clostridium difficile</i> toxin TcdB into host cellsHeather K Kroh, Ramyavardhanee Chandrasekaran, Zhifen Zhang, et al.
Journal of Virology|February 13, 2015
An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionMark Zanin, Zhen-Yong Keck, G Jonah Rainey, et al.
Arthritis and Rheumatism|May 28, 2010
Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffoldMaria-Concetta Veri, Stephen Burke, Ling Huang, et al.
Blood|February 9, 2011
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphomaPaul A Moore, Wenjun Zhang, G Jonah Rainey, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Immunological Methods|July 9, 2013
A mammalian expression system for high throughput antibody screeningLinda Xu, Xiaofang Jin, G Jonah Rainey, et al.
The Journal of Biological Chemistry|March 5, 2017
An antidote approach to reduce risk and broaden utility of antibody-based therapeuticsAlyse D Portnoff, Cuihua Gao, M Jack Borrok, et al.
The Journal of Biological Chemistry|January 20, 2017
Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific AntibodySrinath Kasturirangan, G Jonah Rainey, Linda Xu, et al.
The Journal of Biological Chemistry|July 15, 2017
Use of a neutralizing antibody helps identify structural features critical for binding of <i>Clostridium difficile</i> toxin TcdA to the host cell surfaceHeather K Kroh, Ramyavardhanee Chandrasekaran, Kim Rosenthal, et al.
The Journal of Biological Chemistry|February 8, 2018
Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signalingJenny Sandmark, Göran Dahl, Linda Öster, et al.
The Journal of Biological Chemistry|November 29, 2017
A neutralizing antibody that blocks delivery of the enzymatic cargo of <i>Clostridium difficile</i> toxin TcdB into host cellsHeather K Kroh, Ramyavardhanee Chandrasekaran, Zhifen Zhang, et al.
Journal of Virology|February 13, 2015
An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionMark Zanin, Zhen-Yong Keck, G Jonah Rainey, et al.
Arthritis and Rheumatism|May 28, 2010
Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffoldMaria-Concetta Veri, Stephen Burke, Ling Huang, et al.
Blood|February 9, 2011
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphomaPaul A Moore, Wenjun Zhang, G Jonah Rainey, et al.
Pageof 1